首页 | 本学科首页   官方微博 | 高级检索  
     

卡托普利降低2型糖尿病肾病患者尿蛋白的探讨
引用本文:周岳来. 卡托普利降低2型糖尿病肾病患者尿蛋白的探讨[J]. 现代中西医结合杂志, 2000, 9(22): 2199-2200
作者姓名:周岳来
作者单位:江苏省兴化市第三人民医院!225700
摘    要:目的 :探讨血管紧张素转换酶抑制剂——卡托普利降低糖尿病肾病患者的尿蛋白的机理。方法 :对 37例 2型糖尿病肾病患者随机分两组对照研究。结果 :应用卡托普利组糖尿病肾病患者治疗后能显著降低尿蛋白的排泄量 (P <0 .0 1)。而未用卡托普利组治疗前后无明显变化 (P >0 .0 5 )。结论 :卡托普利能有效降低糖尿病肾病患者的尿蛋白。

关 键 词:糖尿病肾病  血管紧张素转换酶抑制剂  卡托普利  尿蛋白

The study of catopril reduce the urine protein of diabetic nephropathy in type 2 diabetes
Zhou Yuelai The Third Hospital of Xinghua,Jiangsu Province. The study of catopril reduce the urine protein of diabetic nephropathy in type 2 diabetes[J]. Modern Journal of Integrated Chinese Traditional and Western Medicine, 2000, 9(22): 2199-2200
Authors:Zhou Yuelai The Third Hospital of Xinghua  Jiangsu Province
Affiliation:Zhou Yuelai The Third Hospital of Xinghua,Jiangsu Province 225700
Abstract:Objective: It is to study the mechanism of angiotensin converting enzyme inhibitor-catopric reduce the urine protein of diabetic nephropathy. Methods: 37 patients with diabetic nephropathy in type 2 diabetes were divided randomly into two grouds as control study. Results: Urinary albumin excretion was significantly less after treatment in the catopril group(P<0.01). No significant changes were observed without using catopril group(P>0.05). Conclusion: Catopril can effectively reduce the urine protein of diabetic nephropathy patients.
Keywords:diabetic nephropathy angiotensin converting enzyme inhibitor catopril Urine protl
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号